What is the current Buerger’s Disease Diagnosis market size?

The Buerger’s Disease Diagnosis market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Buerger’s Disease Diagnosis market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Buerger’s Disease Diagnosis market?

Increasing prevalence and advancements in diagnostic technologies are key drivers of the market.

What are the major challenges facing the Buerger’s Disease Diagnosis market?

Limited awareness and high diagnostic costs are significant challenges in the market.

Which regions are leading the Buerger’s Disease Diagnosis market?

North America and Europe are currently leading the market due to advanced healthcare infrastructure.

Who are the top companies in the Buerger’s Disease Diagnosis market?

Major players include pharmaceutical and biotechnology companies like Pfizer and Johnson & Johnson.

What future opportunities exist in the Buerger’s Disease Diagnosis market?

Emerging markets and innovative diagnostic technologies present significant future opportunities.

How is technology impacting the Buerger’s Disease Diagnosis market?

Advances in medical imaging and genetic testing are improving diagnosis accuracy and efficiency.

What is the current regulatory landscape for the Buerger’s Disease Diagnosis market?

Regulatory frameworks focus on ensuring safety and efficacy of diagnostic products and treatments.

How will the Buerger’s Disease Diagnosis market evolve in the next 5 years?

The market will experience significant growth driven by increasing demand for effective diagnostic solutions.

Buerger’s Disease Diagnosis Expansion Opportunities & Forecast Analysis 2033

Buerger’s Disease Diagnosis by Application (Hospitals, Clinics, Medical Research Centers, Academic Institutes, Others), by Types (Blood Tests, The Allen’s Test, Angiogram, Tissue Biopsy, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Buerger’s Disease Diagnosis Market Overview

The Buerger’s Disease Diagnosis market refers to the industry involved in the diagnosis and treatment of Buerger’s disease, a rare disorder that affects the blood vessels in the arms and legs. As the Buerger’s Disease Diagnosis market size is expected to grow, driven by an increasing prevalence of the disease and advancements in diagnostic technologies, the growth outlook and market forecast are becoming increasingly important for industry stakeholders. The industry expansion is anticipated to be driven by the development of new diagnostic tests and the rising awareness about the disease, with the global Buerger’s Disease Diagnosis market size estimated to be around $1.4 billion in 2025.

Loading chart…

The Buerger’s Disease Diagnosis market is expected to grow at a CAGR of around 8% from 2026 to 2033, driven by macro drivers such as an increasing prevalence of the disease, advancements in diagnostic technologies, and rising awareness about the disease. Key forces shaping the industry include technology shifts, such as the development of new diagnostic tests, regulations, such as the increasing scrutiny of diagnostic test approvals, and consumer behavior, such as the growing demand for personalized medicine. The largest region for the Buerger’s Disease Diagnosis market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing prevalence of the disease and the rising awareness about the disease in these regions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	1.88 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	FUJIFILM Holdings; GE Healthcare; Koninklijke Philips; Pluristem Therapeutics; Shimadzu Corporation; Siemens Healthcare GmbH; Stempeutics Research; Canon Medical Systems Corporation; t2cure GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Buerger’s Disease Diagnosis market is poised for growth, driven by increasing awareness and advancements in diagnostic technologies. The market dynamics are influenced by various factors, including the growing prevalence of Buerger’s disease, technological advancements, and the need for accurate diagnosis and treatment.

Growth Drivers2 items

Advances in medical imaging technologies, such as angiography and magnetic resonance imaging (MRI), have improved the accuracy of Buerger’s disease diagnosis, contributing to the growth of the Buerger’s Disease Diagnosis market size.

The growth forecast of the Buerger’s Disease Diagnosis market is also driven by the increasing adoption of minimally invasive diagnostic procedures, which reduce the risk of complications and improve patient outcomes.

Restraints2 items

The high cost of diagnostic procedures, including medical imaging and laboratory tests, can limit access to Buerger’s disease diagnosis, particularly in low- and middle-income countries, thereby restraining the growth of the Buerger’s Disease Diagnosis market.

The lack of awareness about Buerger’s disease and its symptoms among patients and healthcare professionals can also hinder the growth of the Buerger’s Disease Diagnosis market, as it may lead to delayed or incorrect diagnosis.

Opportunities2 items

The increasing demand for non-invasive diagnostic tests, such as blood tests and genetic testing, presents opportunities for growth in the Buerger’s Disease Diagnosis market, as these tests can provide accurate and timely diagnosis with minimal risk to patients.

The emerging markets in Asia-Pacific and Latin America offer significant opportunities for growth in the Buerger’s Disease Diagnosis market, driven by the increasing prevalence of Buerger’s disease and improving healthcare infrastructure in these regions.

Challenges2 items

The complexity of Buerger’s disease diagnosis, which requires a combination of clinical evaluation, medical imaging, and laboratory tests, can pose challenges for healthcare professionals and patients, leading to delayed or incorrect diagnosis.

The limited availability of effective treatments for Buerger’s disease can also pose challenges for the Buerger’s Disease Diagnosis market, as it may limit the demand for diagnostic tests and treatments, thereby affecting the overall growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment of the Buerger’s Disease Diagnosis market refers to the various uses of diagnostic techniques and tools for identifying and managing the disease. This segment is crucial in understanding the Buerger’s Disease Diagnosis segmentation, as it highlights the different areas where diagnosis is applied, such as hospitals, clinics, and research institutions. The application segment contributes significantly to the overall market size, as it encompasses a broad range of diagnostic practices.

The Types segment of the Buerger’s Disease Diagnosis market is categorized into subtypes, including [object Object] and [object Object]. This segmentation is vital in understanding the market taxonomy, as it provides insights into the specific diagnostic methods used, such as laboratory tests, imaging tests, and physical examinations. The types segment plays a significant role in determining the overall market size, as it influences the demand for diagnostic products and services.

Buerger’s Disease Diagnosis Segmentation Breakdown12 items

Application

Hospitals

Clinics

Medical Research Centers

Academic Institutes

Others

Types

Blood Tests

The Allen’s Test

Angiogram

Tissue Biopsy

Others

Regional Insights

Loading chart…

The Buerger’s Disease Diagnosis market growth is anticipated to vary across regions, with North America emerging as the largest region, driven by key factors such as high adoption of advanced diagnostic technologies, favorable policies supporting healthcare infrastructure development, and significant investments in research and development. The demographics of an aging population and increasing healthcare awareness also contribute to the region's dominance.

In terms of regional forecast, the Asia Pacific region is expected to be the fastest-growing, fueled by ecosystem maturity, rising infrastructure development, and growing demand for diagnostic services. Government initiatives and private sector investments are also expected to drive growth in this region. Europe and Latin America will also experience significant growth, driven by increasing awareness of Buerger's disease and expanding healthcare access. The Middle East & Africa region will witness moderate growth, driven by growing healthcare expenditure and improving infrastructure.

Key Drivers by Region5 items

North America: high adoption of advanced diagnostic technologies, favorable policies, significant investments

Asia Pacific: ecosystem maturity, rising infrastructure development, growing demand

Europe: increasing awareness, expanding healthcare access, government initiatives

Latin America: growing healthcare access, increasing awareness, private sector investments

Middle East & Africa: growing healthcare expenditure, improving infrastructure, government initiatives

Competitive Landscape

The Buerger’s Disease Diagnosis market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Buerger’s Disease Diagnosis competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and strategic partnerships, while local companies often prioritize regional expansion and localization.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must develop unique value propositions, leveraging technology, service models, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

FUJIFILM Holdings: regional expansion

GE Healthcare: innovation pipeline

Koninklijke Philips: premium pricing

Pluristem Therapeutics: OEM tie-ups

Shimadzu Corporation: local manufacturing

Siemens Healthcare GmbH: vertical integration

Key Buerger’s Disease Diagnosis Companies9 items

FUJIFILM Holdings

GE Healthcare

Koninklijke Philips

Pluristem Therapeutics

Shimadzu Corporation

Siemens Healthcare GmbH

Stempeutics Research

Canon Medical Systems Corporation

t2cure GmbH

Market Ecosystem

The Buerger’s Disease Diagnosis ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three primary tiers: upstream, midstream, and downstream. Upstream participants, including technology providers and suppliers, develop and provide the foundational components and technologies that enable Buerger’s Disease Diagnosis. Midstream entities, such as system integrators and distributors, facilitate the integration and distribution of these technologies. Downstream, end users, including healthcare providers and patients, ultimately adopt and utilize these solutions, creating and capturing value within the ecosystem.

Technology providers — Develop diagnostic technologies

OEMs / manufacturers — Produce medical devices and equipment

System integrators / EPCs — Integrate diagnostic systems and solutions

Distributors / channel partners — Distribute diagnostic products and services

Service providers / after-sales — Offer maintenance and support services

End users / buyers — Adopt and utilize diagnostic solutions

Regulators/standards bodies — Establish and enforce diagnostic standards

Within the Buerger’s Disease Diagnosis ecosystem, control points are primarily held by regulators and standards bodies, as well as technology providers, who influence adoption through innovation and interoperability. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the development and distribution of diagnostic solutions. Furthermore, switching costs and interoperability requirements can create barriers to entry for new participants. As the ecosystem differs by region, due to varying regulatory environments and healthcare infrastructure, a comprehensive value chain analysis is essential to understanding the intricacies of the Buerger’s Disease Diagnosis ecosystem and identifying opportunities for growth and collaboration.

Recent Industry Insights

The Buerger’s Disease Diagnosis industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have accelerated the development of novel diagnostic tools. Notable mergers and acquisitions have also led to the expansion of diagnostic capabilities, enhancing the overall market landscape. Furthermore, the launch of advanced imaging technologies has improved diagnostic accuracy, enabling healthcare professionals to provide more effective treatment plans. Regulatory changes have also played a crucial role in shaping the industry, with a growing emphasis on personalized medicine and targeted therapies. As a result, the Buerger’s Disease Diagnosis market is expected to experience steady growth, driven by increasing demand for accurate and efficient diagnostic solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Buerger’s Disease Diagnosis market. The market attractiveness is moderate, driven by increasing awareness and advancements in diagnostic technologies. The competitive intensity is high, with key players investing in research and development to improve diagnosis accuracy. The long-term outlook for the Buerger’s Disease Diagnosis market outlook is positive, with growing demand for effective diagnostic solutions. The innovation landscape is evolving, with emerging technologies such as genetic testing and biomarker identification. However, the demand–supply balance is a concern, with a shortage of skilled professionals in some regions. Key risk factors include regulatory changes and reimbursement uncertainties, which may impact market growth.

11 items

1. Executive Summary

2. Buerger’s Disease Diagnosis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Buerger’s Disease Diagnosis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Buerger’s Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Medical Research Centers

6.1.4. Academic Institutes

6.1.5. Others

6.2. Global Buerger’s Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Tests

6.2.2. The Allen’s Test

6.2.3. Angiogram

6.2.4. Tissue Biopsy

6.2.5. Others

6.3. Global Buerger’s Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Buerger’s Disease Diagnosis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Buerger’s Disease Diagnosis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Buerger’s Disease Diagnosis Market Competition by Key Manufacturers

8.1. Global Buerger’s Disease Diagnosis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Buerger’s Disease Diagnosis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. FUJIFILM Holdings

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Koninklijke Philips

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Pluristem Therapeutics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shimadzu Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens Healthcare GmbH

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Stempeutics Research

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Canon Medical Systems Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. t2cure GmbH

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Buerger’s Disease Diagnosis Market

Figure 4: Global Buerger’s Disease Diagnosis Market: Drivers

Figure 5: Global Buerger’s Disease Diagnosis Market: Challenges

Figure 6: Global Buerger’s Disease Diagnosis Market: Trends

Figure 7: Global Buerger’s Disease Diagnosis Market: Opportunity

Figure 8: Global Buerger’s Disease Diagnosis Market: Restraint

Figure 9: Global Buerger’s Disease Diagnosis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Buerger’s Disease Diagnosis Market Value (USD Million) By Region

Figure 15: Global Buerger’s Disease Diagnosis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Buerger’s Disease Diagnosis Market Value (USD Million) By Region

Figure 23: Global Buerger’s Disease Diagnosis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Buerger’s Disease Diagnosis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Buerger’s Disease Diagnosis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Buerger’s Disease Diagnosis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Buerger’s Disease Diagnosis Market Value (USD Million) By Region

Table 10: Global Buerger’s Disease Diagnosis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Buerger’s Disease Diagnosis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Buerger’s Disease Diagnosis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Buerger’s Disease Diagnosis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: FUJIFILM Holdings Basic Information And Sales Area

Table 31: FUJIFILM Holdings. Products Portfolio

Table 32: GE Healthcare Basic Information And Sales Area

Table 33: GE Healthcare. Products Portfolio

Table 34: Koninklijke Philips Basic Information And Sales Area

Table 35: Koninklijke Philips. Products Portfolio

Table 36: Pluristem Therapeutics Basic Information And Sales Area

Table 37: Pluristem Therapeutics. Products Portfolio

Table 38: Shimadzu Corporation Basic Information And Sales Area

Table 39: Shimadzu Corporation. Products Portfolio

Table 40: Siemens Healthcare GmbH Basic Information And Sales Area

Table 41: Siemens Healthcare GmbH. Products Portfolio

Table 42: Stempeutics Research Basic Information And Sales Area

Table 43: Stempeutics Research. Products Portfolio

Table 44: Canon Medical Systems Corporation Basic Information And Sales Area

Table 45: Canon Medical Systems Corporation. Products Portfolio

Table 46: t2cure GmbH Basic Information And Sales Area

Table 47: t2cure GmbH. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Buerger’s Disease Diagnosis Market Value (USD Million) By Region

Table 53: Global Buerger’s Disease Diagnosis Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Buerger’s Disease Diagnosis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	1.88 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	FUJIFILM Holdings; GE Healthcare; Koninklijke Philips; Pluristem Therapeutics; Shimadzu Corporation; Siemens Healthcare GmbH; Stempeutics Research; Canon Medical Systems Corporation; t2cure GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Buerger’s Disease Diagnosis Segmentation Breakdown12 items

Application

Hospitals

Clinics

Medical Research Centers

Academic Institutes

Others

Types

Blood Tests

The Allen’s Test

Angiogram

Tissue Biopsy

Others

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: high adoption of advanced diagnostic technologies, favorable policies, significant investments

Asia Pacific: ecosystem maturity, rising infrastructure development, growing demand

Europe: increasing awareness, expanding healthcare access, government initiatives

Latin America: growing healthcare access, increasing awareness, private sector investments

Middle East & Africa: growing healthcare expenditure, improving infrastructure, government initiatives

Competitive Landscape

FUJIFILM Holdings: regional expansion

GE Healthcare: innovation pipeline

Koninklijke Philips: premium pricing

Pluristem Therapeutics: OEM tie-ups

Shimadzu Corporation: local manufacturing

Siemens Healthcare GmbH: vertical integration

Key Buerger’s Disease Diagnosis Companies9 items

FUJIFILM Holdings

GE Healthcare

Koninklijke Philips

Pluristem Therapeutics

Shimadzu Corporation

Siemens Healthcare GmbH

Stempeutics Research

Canon Medical Systems Corporation

t2cure GmbH

Market Ecosystem

Technology providers — Develop diagnostic technologies

OEMs / manufacturers — Produce medical devices and equipment

System integrators / EPCs — Integrate diagnostic systems and solutions

Distributors / channel partners — Distribute diagnostic products and services

Service providers / after-sales — Offer maintenance and support services

End users / buyers — Adopt and utilize diagnostic solutions

Regulators/standards bodies — Establish and enforce diagnostic standards

Recent Industry Insights

Analyst Overview

Table of Contents